Pein F, Hartmann O
Service de chimiothérapie, Centre Paul-Papin, Angers, France.
Bull Cancer. 1988;75(1):83-6.
Thanks to the recent progress made concerning the biology of neuroblastoma, we can now define with greater accuracy the progression and prognosis of these tumours. Several biologic profiles distinguish the neuroblastoma at stage IV-S, the prognosis of which is usually good, thus providing it with a true biological identity.
由于近期在神经母细胞瘤生物学方面取得的进展,我们现在能够更准确地界定这些肿瘤的进展和预后情况。几种生物学特征区分出了IV-S期神经母细胞瘤,其预后通常良好,从而赋予了它真正的生物学特性。